Purpose The goals were to develop a working and inclusive definition of access to eye care,
identify gaps in the current system that preclude access, and highlight recommendations that …

Diabetic retinopathy is one of the major complications of diabetes mellitus and a leading
cause of visual loss. Diabetic macular edema (DME) is an ocular manifestation of the …

Intravitreal injections and implants are used to deliver drugs to the retina because
therapeutic levels of these medications cannot be provided by topical administration (ie eye …

Purpose The coronavirus pandemic has prompted unprecedented delays to treatment with
anti-VEGF intravitreal injections due to the need to reduce hospital attendances and …

PURPOSE To report the 100-week outcomes from the KESTREL and KITE trials. DESIGN
Two phase 3, double-masked, active-controlled, randomized trials. METHODS Patients with …

Diabetic retinal disease (DRD) is the leading cause of blindness among working-aged
individuals with diabetes. In the United States, underserved and minority populations are …

Purpose This study characterizes the association of risk factors including race, ethnicity, and
insurance status with presenting visual acuity (VA) and diabetic retinopathy (DR) severity in …

Aims To provide 2-year follow-up data on eyes with diabetic macular edema (DME) that
were non-responsive after three initial anti-vascular endothelial growth factor (VEGF) …

Rationale: United States veterans represent an important population to study sarcoidosis.
Their unique history of environmental exposures, wide geographic distribution, and long …

Purpose: To evaluate the rate of compliance and the reasons for loss to follow-up in Indian
patients with diabetic macular edema (DME), age-related macular degeneration (AMD), and …